Mimetas Operations US, CO.

Gaithersburg, MD Mimetas Operations US Co

UEI
M9RJXA9M7L68
CAGE
8NJK1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
704 Quince Orchard Rd #260, Gaithersburg, MD 20878, USA
Website
mimetas.com
Founded
2011
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Mimetas Operations US, CO.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Mimetas organoplate graft 3 lane 64 chip plate microfluidic 3D cell culture plate 6401-400-b Contract · 75N95022P00442 National Institute on Drug Abuse $30,096
Acquisition of organoplate graft to be used for sars_COV-2 project Contract · 75N95022P00365 National Institute on Drug Abuse $150,480
To procure a 6401-400-b organoplate graft. Contract · 75N95021P00651 National Institute on Drug Abuse $0
Organoplate graft microfluidic 3D cell culture plates, catalog number: 6401-400-b Contract · 75N95021P00280 National Institute on Drug Abuse $29,125
This is a covid-19/coronavirus related contract action for: organoplate graft, QTY: 25, part no. 6401-400-b. Contract · 75N95021P00070 National Institute on Drug Abuse $29,075

About Mimetas Operations US, CO.

Products and Services

The government contractor primarily provides microfluidic 3D cell culture plates, specifically the Organoplate Graft (part number 6401-400-B). These products are used in various scientific research projects, including those related to SARS-CoV-2 and COVID-19. Over time, the contractor's product offerings have remained consistent, focusing on the Organoplate Graft.

Customers

The contractor's primary customer is the Department of Health and Human Services (HHS), specifically the National Institutes of Health (NIH). The NIH has consistently awarded contracts to this contractor over time. The contractor's products have been used in various projects, including those related to COVID-19 and SARS-CoV-2.

Vehicles

The contract vehicle used for these awards is the Purchase Order. This has remained consistent throughout the contract award history.

Summary

The government contractor has a consistent history of providing Organoplate Grafts to the NIH for various research projects. The NIH has consistently been the contractor's primary customer, and the Purchase Order has been the consistent contract vehicle. The contractor's products have been used in critical research projects, including those related to COVID-19 and SARS-CoV-2.

Data

The analysis is based on six contracts awarded between 08/26/20 and 08/11/22.

Quick answers

What is Mimetas Operations US, CO.'s UEI?

Mimetas Operations US, CO.'s Unique Entity ID (UEI) in SAM.gov is M9RJXA9M7L68.

What is Mimetas Operations US, CO.'s CAGE code?

Mimetas Operations US, CO.'s CAGE code is 8NJK1.

What is Mimetas Operations US, CO.'s primary NAICS code?

Mimetas Operations US, CO.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Mimetas Operations US, CO. located?

Mimetas Operations US, CO.'s physical address in SAM.gov is 704 Quince Orchard Rd #260, Gaithersburg, MD 20878, USA.

Is Mimetas Operations US, CO. registered in SAM.gov?

Yes. Mimetas Operations US, CO.'s SAM.gov registration is active through April 22, 2027.

What is Mimetas Operations US, CO.'s most recent federal award?

Mimetas Operations US, CO.'s most recent federal contract award is Mimetas organoplate graft 3 lane 64 chip plate microfluidic 3D cell culture plate 6401-400-b (75N95022P00442), from National Institute on Drug Abuse, on August 11, 2022.

On GovTribe

See Mimetas Operations US, CO.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors